Long-term outcomes among African-American and white women with breast cancer: What is the impact of comorbidity?

Journal of Geriatric Oncology

Volumn 5, Issue 3, 2014, Pages 266-275

  Izano, Monika ^a   Satariano, William A ^b   Tammemagi, Martin C ^c   Ragland, David ^b   Moore, Dan H ^a   Allen, Elaine ^a   Naeim, Arash ^d   Sehl, Mary E ^d   Hiatt, Robert A ^a,e   Kerlikowske, Karla ^a   Sofrygin, Oleg ^b   Braithwaite, Dejana ^a,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BROCK UNIVERSITY   (Canada)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Breast cancer; Cohort study; Comorbidity; Mortality; Racial disparity; Survival

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BODY MASS; BREAST CANCER; CANCER MORTALITY; CANCER PROGNOSIS; CANCER STAGING; CAUCASIAN; CHARLSON COMORBIDITY INDEX; COMORBIDITY; EDUCATIONAL STATUS; FEMALE; FINANCIAL DEFICIT; FOLLOW UP; FUNCTIONAL DISEASE; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; RACE DIFFERENCE; BREAST TUMOR; EPIDEMIOLOGY; ETHNOLOGY; MICHIGAN; MIDDLE AGED; PROGNOSIS; VERY ELDERLY;

ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COMORBIDITY; EPIDEMIOLOGIC METHODS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MICHIGAN; MIDDLE AGED; PROGNOSIS;

EID: 84905039443     PISSN: 18794068     EISSN: 18794076     Source Type: Journal    
DOI: 10.1016/j.jgo.2014.02.003     Document Type: Article

References (50)

1. SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations), based on November 2011 SEER data submission 2012, National Cancer Institute Bethesda, MD, [Epub April 2012]. A.M. Howlader NN, M. Krapcho, N. Neyman, R. Aminou, W. Waldron, S.F. Altekruse, C.L. Kosary, J. Ruhl, Z. Tatalovich, H. Cho, A. Mariotto, M.P. Eisner, D.R. Lewis, H.S. Chen, E.J. Feuer, K.A. Cronin (Eds.).
2. Adams S.A., Butler W.M., Fulton J., Heiney S.P., Williams E.M., Delage A.F., et al. Racial disparities in breast cancer mortality in a multiethnic cohort in the Southeast. Cancer 2012, 118(10):2693-2699. [Epub 2011/09/29].
3. Eley J.W., Hill H.A., Chen V.W., Austin D.F., Wesley M.N., Muss H.B., et al. Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study. JAMA 1994, 272(12):947-954. [Epub 1994/09/28].
4. Chen V.W., Correa P., Kurman R.J., Wu X.C., Eley J.W., Austin D., et al. Histological characteristics of breast carcinoma in blacks and whites. Cancer Epidemiol Biomarkers Prev 1994, 3(2):127-135. Epub 1994/03/01.
5. Cunningham J.E., Butler W.M. Racial disparities in female breast cancer in South Carolina: clinical evidence for a biological basis. Breast Cancer Res Treat 2004, 88(2):161-176. Epub 2004/11/27.
6. Fisher E.R., Anderson S., Redmond C., Fisher B. Pathologic findings from the National Surgical Adjuvant Breast Project protocol B-06. 10-year pathologic and clinical prognostic discriminants. Cancer 1993, 71(8):2507-2514.
7. Joslyn S.A., West M.M. Racial differences in breast carcinoma survival. Cancer 2000, 88(1):114-123. Epub 2000/01/05.
8. Strzelczyk J.J., Dignan M.B. Disparities in adherence to recommended followup on screening mammography: interaction of sociodemographic factors. Ethn Dis 2002, 12(1):77-86. Epub 2002/03/27.
9. Griggs J.J., Sorbero M.E., Stark A.T., Heininger S.E., Dick A.W. Racial disparity in the dose and dose intensity of breast cancer adjuvant chemotherapy. Breast Cancer Res Treat 2003, 81(1):21-31. (Epub 2003/10/09).
10. Shavers V.L., Brown M.L. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst 2002, 94(5):334-357. Epub 2002/03/07.
11. Joslyn S.A. Racial differences in treatment and survival from early-stage breast carcinoma. Cancer 2002, 95(8):1759-1766. Epub 2002/10/05.
12. Li C.I., Malone K.E., Daling J.R. Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med 2003, 163(1):49-56. Epub 2003/01/14.
13. Lannin D.R., Mathews H.F., Mitchell J., Swanson M.S., Swanson F.H., Edwards M.S. Influence of socioeconomic and cultural factors on racial differences in late-stage presentation of breast cancer. JAMA 1998, 279(22):1801-1807. Epub 1998/06/17.
14. Rizzo M., Lund M.J., Mosunjac M., Bumpers H., Holmes L., O'Regan R., et al. Characteristics and treatment modalities for African American women diagnosed with stage III breast cancer. Cancer 2009, 115(13):3009-3015. [Epub 2009/05/26].
15. Tammemagi C.M., Nerenz D., Neslund-Dudas C., Feldkamp C., Nathanson D. Comorbidity and survival disparities among black and white patients with breast cancer. JAMA 2005, 294(14):1765-1772. [Epub 2005/10/13].
16. West D.W., Satariano W.A., Ragland D.R., Hiatt R.A. Comorbidity and breast cancer survival: a comparison between black and white women. Ann Epidemiol 1996, 6(5):413-419. Epub 1996/09/01.
17. Braithwaite D., Tammemagi C.M., Moore D.H., Ozanne E.M., Hiatt R.A., Belkora J., et al. Hypertension is an independent predictor of survival disparity between African-American and white breast cancer patients. Int J Cancer 2009, 124(5):1213-1219. Epub 2008/12/06.
18. Hershman D., McBride R., Jacobson J.S., Lamerato L., Roberts K., Grann V.R., et al. Racial disparities in treatment and survival among women with early-stage breast cancer. J Clin Oncol 2005, 23(27):6639-6646. Epub 2005/09/20.
19. Given B., Given C., Azzouz F., Stommel M. Physical functioning of elderly cancer patients prior to diagnosis and following initial treatment. Nurs Res 2001, 50(4):222-232. Epub 2001/08/02.
20. Braithwaite D., Satariano W.A., Sternfeld B., Hiatt R.A., Ganz P.A., Kerlikowske K., et al. Long-term prognostic role of functional limitations among women with breast cancer. J Natl Cancer Inst 2010, 102(19):1468-1477. Epub 2010/09/24.
21. Extermann M., Overcash J., Lyman G.H., Parr J., Balducci L. Comorbidity and functional status are independent in older cancer patients. J Clin Oncol 1998, 16(4):1582-1587. Epub 1998/04/29.
22. Kroenke C.H., Rosner B., Chen W.Y., Kawachi I., Colditz G.A., Holmes M.D. Functional impact of breast cancer by age at diagnosis. J Clin Oncol 2004, 22(10):1849-1856. Epub 2004/05/15.
23. Izano M., Satariano W.A., Hiatt R.A., Braithwaite D. The impact of functional limitations on long-term outcomes among African-American and white women with breast cancer: a cohort study. BMJ Open 2013, 3(10):e003232. [Epub 2013/10/12].
24. Satariano W.A., Ragland D.R. The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med 1994, 120(2):104-110. [Epub 1994/01/15].
25. Satariano W.A., Ragland D.R. Upper-body strength and breast cancer: a comparison of the effects of age and disease. J Gerontol A Biol Sci Med Sci 1996, 51(5):M215-M219. [Epub 1996/09/01].
26. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40(5):373-383. [Epub 1987/01/01].
27. Tice J.A., Kanaya A., Hue T., Rubin S., Buist D.S., Lacroix A., et al. Risk factors for mortality in middle-aged women. Arch Intern Med 2006, 166(22):2469-2477. [Epub 2006/12/13].
28. Lee S.J., Lindquist K., Segal M.R., Covinsky K.E. Development and validation of a prognostic index for 4-year mortality in older adults. JAMA 2006, 295(7):801-808. [Epub 2006/02/16].
29. Schonberg M.A., Davis R.B., McCarthy E.P., Marcantonio E.R. Index to predict 5-year mortality of community-dwelling adults aged 65 and older using data from the National Health Interview Survey. J Gen Intern Med 2009, 24(10):1115-1122. [Epub 2009/08/04].
30. Schonberg M.A., Davis R.B., McCarthy E.P., Marcantonio E.R. External validation of an index to predict up to 9-year mortality of community-dwelling adults aged 65 and older. J Am Geriatr Soc 2011, 59(8):1444-1451. [Epub 2011/07/30].
31. Satariano W.A., Ragheb N.E., Branch L.G., Swanson G.M. Difficulties in physical functioning reported by middle-aged and elderly women with breast cancer: a case-control comparison. J Gerontol 1990, 45(1):M3-M11. [Epub 1990/01/01].
32. Satariano W.A., Ragland D.R., DeLorenze G.N. Limitations in upper-body strength associated with breast cancer: a comparison of black and white women. J Clin Epidemiol 1996, 49(5):535-544. [Epub 1996/05/01].
33. Nagi S.Z. An epidemiology of disability among adults in the United States. Milbank Mem Fund Q Health Soc 1976, 54(4):439-467. [Epub 1976/01/01].
34. Greenland S. Modeling and variable selection in epidemiologic analysis. Am J Public Health 1989, 79(3):340-349. [Epub 1989/03/01].
35. Prentice R.L., Kalbfleisch J.D. Hazard rate models with covariates. Biometrics 1979, 35(1):25-39. [Epub 1979/03/01].
36. Martinussen T., Scheike T.H. Dynamic regression models for survival data 2006, Springer, New York, NY, [xiii, 470 pp.].
37. Breen N., Feuer E.J., Depuy S., Zapka J. The effect of Medicare reimbursement for screening mammography on utilization and payment. National Cancer Institute Breast Cancer Screening Consortium. Public Health Rep 1997, 112(5):423-432. [Epub 1997/11/05].
38. Braithwaite D., Moore D.H., Satariano W.A., Kwan M.L., Hiatt R.A., Kroenke C., et al. Prognostic impact of comorbidity among long-term breast cancer survivors: results from the LACE study. Cancer Epidemiol Biomarkers Prev 2012, 21(7):1115-1125. [Epub 2012/05/11].
39. Nagel G., Wedding U., Rohrig B., Katenkamp D. The impact of comorbidity on the survival of postmenopausal women with breast cancer. J Cancer Res Clin Oncol 2004, 130(11):664-670. [Epub 2004/08/10].
40. Patterson R.E., Flatt S.W., Saquib N., Rock C.L., Caan B.J., Parker B.A., et al. Medical comorbidities predict mortality in women with a history of early stage breast cancer. Breast Cancer Res Treat 2010, 122(3):859-865. [Epub 2010/01/16].
41. Yancik R., Wesley M.N., Ries L.A., Havlik R.J., Edwards B.K., Yates J.W. Effect of age and comorbidity in postmenopausal breast cancer patients aged 55years and older. JAMA 2001, 285(7):885-892. [Epub 2001/03/17].
42. Scott W.K., Macera C.A., Cornman C.B., Sharpe P.A. Functional health status as a predictor of mortality in men and women over 65. J Clin Epidemiol 1997, 50(3):291-296. [Epub 1997/03/01].
43. Cruz M., Covinsky K., Widera E.W., Stijacic-Cenzer I., Lee S.J. Predicting 10-year mortality for older adults. JAMA 2013, 309(9):874-876. [Epub 2013/03/07].
44. Malenka D.J., McLerran D., Roos N., Fisher E.S., Wennberg J.E. Using administrative data to describe casemix: a comparison with the medical record. J Clin Epidemiol 1994, 47(9):1027-1032. [Epub 1994/09/01].
45. Kieszak S.M., Flanders W.D., Kosinski A.S., Shipp C.C., Karp H. A comparison of the Charlson comorbidity index derived from medical record data and administrative billing data. J Clin Epidemiol 1999, 52(2):137-142. [Epub 1999/04/14].
46. Powell H., Lim L.L., Heller R.F. Accuracy of administrative data to assess comorbidity in patients with heart disease. An Australian perspective. J Clin Epidemiol 2001, 54(7):687-693. [Epub 2001/07/05].
47. Preen D.B., Holman C.D., Lawrence D.M., Baynham N.J., Semmens J.B. Hospital chart review provided more accurate comorbidity information than data from a general practitioner survey or an administrative database. J Clin Epidemiol 2004, 57(12):1295-1304. [Epub 2004/12/25].
48. Greenfield S., Blanco D.M., Elashoff R.M., Ganz P.A. Patterns of care related to age of breast cancer patients. JAMA 1987, 257(20):2766-2770. [Epub 1987/05/22].
49. Newschaffer C.J., Bush T.L., Penberthy L.T. Comorbidity measurement in elderly female breast cancer patients with administrative and medical records data. J Clin Epidemiol 1997, 50(6):725-733. [Epub 1997/06/01].
50. Frasci G., Lorusso V., Panza N., Comella P., Nicolella G., Bianco A., et al. Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer. J Clin Oncol 2000, 18(13):2529-2536. [Epub 2000/07/13].